Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 77

1.

Mediation analysis shows that a decline in self-efficacy mediates the increase in fatigue severity following an initial positive response to cognitive behavioural therapy in Q fever fatigue syndrome.

Breukers EMC, Raijmakers RPH, Nieuwkerk PT, Bleijenberg G, van der Meer JWM, Bleeker-Rovers CP, Keijmel SP, Knoop H.

J Psychosom Res. 2019 Oct 23;127:109841. doi: 10.1016/j.jpsychores.2019.109841. [Epub ahead of print]

PMID:
31734556
2.

Long-Lasting Transcriptional Changes in Circulating Monocytes of Acute Q Fever Patients.

Raijmakers RP, Stenos J, Keijmel SP, Ter Horst R, Novakovic B, Nguyen C, Van Der Meer JW, Netea MG, Bleeker-Rovers CP, Joosten LA, Graves SR.

Open Forum Infect Dis. 2019 Jul 1;6(7). pii: ofz296. doi: 10.1093/ofid/ofz296.

3.

Fludarabine exposure in the conditioning prior to allogeneic hematopoietic cell transplantation predicts outcomes.

Langenhorst JB, van Kesteren C, van Maarseveen EM, Dorlo TPC, Nierkens S, Lindemans CA, de Witte MA, van Rhenen A, Raijmakers R, Bierings M, Kuball J, Huitema ADR, Boelens JJ.

Blood Adv. 2019 Jul 23;3(14):2179-2187. doi: 10.1182/bloodadvances.2018029421.

4.

A possible role for mitochondrial-derived peptides humanin and MOTS-c in patients with Q fever fatigue syndrome and chronic fatigue syndrome.

Raijmakers RPH, Jansen AFM, Keijmel SP, Ter Horst R, Roerink ME, Novakovic B, Joosten LAB, van der Meer JWM, Netea MG, Bleeker-Rovers CP.

J Transl Med. 2019 May 14;17(1):157. doi: 10.1186/s12967-019-1906-3.

5.

Chronic Q fever associated with systemic sclerosis.

Jansen AFM, Raijmakers RPH, van Deuren M, Vonk MC, Bleeker-Rovers CP.

Eur J Clin Invest. 2019 Jul;49(7):e13123. doi: 10.1111/eci.13123. Epub 2019 Jun 6.

PMID:
31077590
6.

A possible link between recurrent upper respiratory tract infections and lower cytokine production in patients with Q fever fatigue syndrome.

Raijmakers RPH, Jansen AFM, Keijmel SP, van der Meer JWM, Joosten LAB, Netea MG, Bleeker-Rovers CP.

Eur J Immunol. 2019 Jul;49(7):1015-1022. doi: 10.1002/eji.201848012. Epub 2019 May 9.

PMID:
31001808
7.

Cytokine profiles in patients with Q fever fatigue syndrome.

Raijmakers RPH, Koeken VACM, Jansen AFM, Keijmel SP, Roerink ME, Joosten LAB, Netea MG, van der Meer JWM, Bleeker-Rovers CP.

J Infect. 2019 May;78(5):349-357. doi: 10.1016/j.jinf.2019.01.006. Epub 2019 Jan 23.

PMID:
30684502
8.

Long-term effect of cognitive behavioural therapy and doxycycline treatment for patients with Q fever fatigue syndrome: One-year follow-up of the Qure study.

Raijmakers RPH, Keijmel SP, Breukers EMC, Bleijenberg G, van der Meer JWM, Bleeker-Rovers CP, Knoop H.

J Psychosom Res. 2019 Jan;116:62-67. doi: 10.1016/j.jpsychores.2018.11.007. Epub 2018 Nov 12.

PMID:
30654996
9.

Tyrosine kinase inhibitor levels matter in treating chronic GVHD.

van der Wagen L, Janssen J, Raijmakers R, Petersen E, de Witte M, de Jong N, Bellido M, Meijer E, Bär B, Jan Boelens J, Huitema A, Kuball J.

Bone Marrow Transplant. 2019 Jul;54(7):1141-1144. doi: 10.1038/s41409-018-0429-5. Epub 2019 Jan 16. No abstract available.

PMID:
30651587
10.

Pitfalls in cytokine measurements - Plasma TGF-β1 in chronic fatigue syndrome.

Roerink ME, van der Schaaf ME, Hawinkels LJAC, Raijmakers RPH, Knoop H, Joosten LAB, van der Meer JWM.

Neth J Med. 2018 Sep;76(7):310-313.

11.

Autoimmunity and B-cell dyscrasia in acute and chronic Q fever: A review of the literature.

Jansen AFM, Raijmakers RPH, Keijmel SP, van der Molen RG, Vervoort GM, van der Meer JWM, van Deuren M, Bleeker-Rovers CP.

Eur J Intern Med. 2018 Aug;54:6-12. doi: 10.1016/j.ejim.2018.06.007. Epub 2018 Jun 19. Review.

PMID:
29908707
12.

Interferon-γ and CXCL10 responses related to complaints in patients with Q fever fatigue syndrome.

Raijmakers RPH, Jansen AFM, Keijmel SP, Schoffelen T, Scholzen A, van der Meer JWM, Joosten LAB, Netea MG, van Deuren M, Bleeker-Rovers CP.

Eur J Clin Microbiol Infect Dis. 2018 Jul;37(7):1385-1391. doi: 10.1007/s10096-018-3265-z. Epub 2018 May 26.

13.

A search for ceramide binding proteins using bifunctional lipid analogs yields CERT-related protein StarD7.

Bockelmann S, Mina JGM, Korneev S, Hassan DG, Müller D, Hilderink A, Vlieg HC, Raijmakers R, Heck AJR, Haberkant P, Holthuis JCM.

J Lipid Res. 2018 Mar;59(3):515-530. doi: 10.1194/jlr.M082354. Epub 2018 Jan 17.

14.

Toll-like receptor 2 induced cytotoxic T-lymphocyte-associated protein 4 regulates Aspergillus-induced regulatory T-cells with pro-inflammatory characteristics.

Raijmakers RPH, Sprenkeler EGG, Aleva FE, Jacobs CWM, Kanneganti TD, Joosten LAB, van de Veerdonk FL, Gresnigt MS.

Sci Rep. 2017 Sep 13;7(1):11500. doi: 10.1038/s41598-017-11738-4.

15.

CXCL9, a promising biomarker in the diagnosis of chronic Q fever.

Jansen AFM, Schoffelen T, Textoris J, Mege JL, Nabuurs-Franssen M, Raijmakers RPH, Netea MG, Joosten LAB, Bleeker-Rovers CP, van Deuren M.

BMC Infect Dis. 2017 Aug 9;17(1):556. doi: 10.1186/s12879-017-2656-6.

16.

A fatal case of disseminated chronic Q fever: a case report and brief review of the literature.

Keijmel SP, Raijmakers RP, Schoffelen T, Salet MC, Bleeker-Rovers CP.

Infection. 2016 Oct;44(5):677-82. doi: 10.1007/s15010-016-0884-0. Epub 2016 Mar 3. Review.

17.

Altered interferon-γ response in patients with Q-fever fatigue syndrome.

Keijmel SP, Raijmakers RP, Bleeker-Rovers CP, van der Meer JW, Netea MG, Schoffelen T, van Deuren M.

J Infect. 2016 Apr;72(4):478-85. doi: 10.1016/j.jinf.2016.01.004. Epub 2016 Jan 25.

PMID:
26820634
18.

Use of physical restraints in Dutch intensive care units: a prospective multicenter study.

van der Kooi AW, Peelen LM, Raijmakers RJ, Vroegop RL, Bakker DF, Tekatli H, van den Boogaard M, Slooter AJ.

Am J Crit Care. 2015 Nov;24(6):488-95. doi: 10.4037/ajcc2015348.

19.

PRIME-XS, a European infrastructure for proteomics.

Raijmakers R, Olsen JV, Aebersold R, Heck AJ.

Mol Cell Proteomics. 2014 Aug;13(8):1901-4. doi: 10.1074/mcp.E114.040162. Epub 2014 Jun 23.

20.

The human peptidylarginine deiminases type 2 and type 4 have distinct substrate specificities.

Assohou-Luty C, Raijmakers R, Benckhuijsen WE, Stammen-Vogelzangs J, de Ru A, van Veelen PA, Franken KL, Drijfhout JW, Pruijn GJ.

Biochim Biophys Acta. 2014 Apr;1844(4):829-36. doi: 10.1016/j.bbapap.2014.02.019. Epub 2014 Mar 2.

PMID:
24594197
21.

Temperature variability during delirium in ICU patients: an observational study.

van der Kooi AW, Kappen TH, Raijmakers RJ, Zaal IJ, Slooter AJ.

PLoS One. 2013 Oct 23;8(10):e78923. doi: 10.1371/journal.pone.0078923. eCollection 2013.

22.

In vivo profiling and visualization of cellular protein-lipid interactions using bifunctional fatty acids.

Haberkant P, Raijmakers R, Wildwater M, Sachsenheimer T, Brügger B, Maeda K, Houweling M, Gavin AC, Schultz C, van Meer G, Heck AJ, Holthuis JC.

Angew Chem Int Ed Engl. 2013 Apr 2;52(14):4033-8. doi: 10.1002/anie.201210178. Epub 2013 Feb 28. No abstract available.

PMID:
23450850
23.

Inhibition of peptidyl-arginine deiminases reverses protein-hypercitrullination and disease in mouse models of multiple sclerosis.

Moscarello MA, Lei H, Mastronardi FG, Winer S, Tsui H, Li Z, Ackerley C, Zhang L, Raijmakers R, Wood DD.

Dis Model Mech. 2013 Mar;6(2):467-78. doi: 10.1242/dmm.010520. Epub 2012 Nov 1.

24.

Peptidylarginine deiminase expression and activity in PAD2 knock-out and PAD4-low mice.

van Beers JJ, Zendman AJ, Raijmakers R, Stammen-Vogelzangs J, Pruijn GJ.

Biochimie. 2013 Feb;95(2):299-308. doi: 10.1016/j.biochi.2012.09.029. Epub 2012 Sep 28.

PMID:
23026755
25.

Deep proteome profiling of circulating granulocytes reveals bactericidal/permeability-increasing protein as a biomarker for severe atherosclerotic coronary stenosis.

Bleijerveld OB, Wijten P, Cappadona S, McClellan EA, Polat AN, Raijmakers R, Sels JW, Colle L, Grasso S, van den Toorn HW, van Breukelen B, Stubbs A, Pasterkamp G, Heck AJ, Hoefer IE, Scholten A.

J Proteome Res. 2012 Nov 2;11(11):5235-44. doi: 10.1021/pr3004375. Epub 2012 Oct 11.

PMID:
23020738
26.

Fully automated isotopic dimethyl labeling and phosphopeptide enrichment using a microfluidic HPLC phosphochip.

Polat AN, Kraiczek K, Heck AJ, Raijmakers R, Mohammed S.

Anal Bioanal Chem. 2012 Nov;404(8):2507-12. doi: 10.1007/s00216-012-6395-7. Epub 2012 Sep 14.

PMID:
22975804
27.

Applications of stable isotope dimethyl labeling in quantitative proteomics.

Kovanich D, Cappadona S, Raijmakers R, Mohammed S, Scholten A, Heck AJ.

Anal Bioanal Chem. 2012 Sep;404(4):991-1009. doi: 10.1007/s00216-012-6070-z. Epub 2012 May 27. Review.

PMID:
22644145
28.

Elevated levels of fibrinogen-derived endogenous citrullinated peptides in synovial fluid of rheumatoid arthritis patients.

Raijmakers R, van Beers JJ, El-Azzouny M, Visser NF, Božič B, Pruijn GJ, Heck AJ.

Arthritis Res Ther. 2012 May 14;14(3):R114.

29.

Oxidative stress-induced modifications of histidyl-tRNA synthetase affect its tRNA aminoacylation activity but not its immunoreactivity.

van Dooren SH, Raijmakers R, Pluk H, Lokate AM, Koemans TS, Spanjers RE, Heck AJ, Boelens WC, van Venrooij WJ, Pruijn GJ.

Biochem Cell Biol. 2011 Dec;89(6):545-53. doi: 10.1139/o11-055. Epub 2011 Nov 2.

PMID:
22047085
30.

Evaluation of the deuterium isotope effect in zwitterionic hydrophilic interaction liquid chromatography separations for implementation in a quantitative proteomic approach.

Di Palma S, Raijmakers R, Heck AJ, Mohammed S.

Anal Chem. 2011 Nov 1;83(21):8352-6. doi: 10.1021/ac2018074. Epub 2011 Sep 30.

PMID:
21899334
31.

RockerBox: analysis and filtering of massive proteomics search results.

van den Toorn HW, Muñoz J, Mohammed S, Raijmakers R, Heck AJ, van Breukelen B.

J Proteome Res. 2011 Mar 4;10(3):1420-4. doi: 10.1021/pr1010185. Epub 2011 Feb 7.

PMID:
21184612
32.

Mapping of citrullinated fibrinogen B-cell epitopes in rheumatoid arthritis by imaging surface plasmon resonance.

van Beers JJ, Raijmakers R, Alexander LE, Stammen-Vogelzangs J, Lokate AM, Heck AJ, Schasfoort RB, Pruijn GJ.

Arthritis Res Ther. 2010;12(6):R219. doi: 10.1186/ar3205. Epub 2010 Dec 23.

33.

Site-specific methionine oxidation in calmodulin affects structural integrity and interaction with Ca2+/calmodulin-dependent protein kinase II.

Snijder J, Rose RJ, Raijmakers R, Heck AJ.

J Struct Biol. 2011 Apr;174(1):187-95. doi: 10.1016/j.jsb.2010.12.002. Epub 2010 Dec 13.

PMID:
21156208
34.

Cleavage specificities of the brother and sister proteases Lys-C and Lys-N.

Raijmakers R, Neerincx P, Mohammed S, Heck AJ.

Chem Commun (Camb). 2010 Dec 14;46(46):8827-9. doi: 10.1039/c0cc02523b. Epub 2010 Oct 18.

PMID:
20953479
35.

Target profiling of a small library of phosphodiesterase 5 (PDE5) inhibitors using chemical proteomics.

Raijmakers R, Dadvar P, Pelletier S, Gouw J, Rumpel K, Heck AJ.

ChemMedChem. 2010 Nov 8;5(11):1927-36. doi: 10.1002/cmdc.201000303.

PMID:
20862763
36.

Dis3-like 1: a novel exoribonuclease associated with the human exosome.

Staals RH, Bronkhorst AW, Schilders G, Slomovic S, Schuster G, Heck AJ, Raijmakers R, Pruijn GJ.

EMBO J. 2010 Jul 21;29(14):2358-67. doi: 10.1038/emboj.2010.122. Epub 2010 Jun 8.

37.

Quantifying cross-tissue diversity in proteasome complexes by mass spectrometry.

Pelletier S, Schuurman KG, Berkers CR, Ovaa H, Heck AJ, Raijmakers R.

Mol Biosyst. 2010 Aug;6(8):1450-3. doi: 10.1039/c004989a. Epub 2010 May 24.

PMID:
20498902
38.

Profiling of N-acetylated protein termini provides in-depth insights into the N-terminal nature of the proteome.

Helbig AO, Gauci S, Raijmakers R, van Breukelen B, Slijper M, Mohammed S, Heck AJ.

Mol Cell Proteomics. 2010 May;9(5):928-39. doi: 10.1074/mcp.M900463-MCP200. Epub 2010 Jan 7.

39.
40.

Phosphatidylethanolamine-binding proteins, including RKIP, exhibit affinity for phosphodiesterase-5 inhibitors.

Dadvar P, Kovanich D, Folkers GE, Rumpel K, Raijmakers R, Heck AJ.

Chembiochem. 2009 Nov 2;10(16):2654-62. doi: 10.1002/cbic.200900452.

PMID:
19760692
41.

Assessing biological variation and protein processing in primary human leukocytes by automated multiplex stable isotope labeling coupled to 2 dimensional peptide separation.

Raijmakers R, Heck AJ, Mohammed S.

Mol Biosyst. 2009 Sep;5(9):992-1003. doi: 10.1039/b901873e. Epub 2009 May 6.

PMID:
19668865
42.

Multiplex peptide stable isotope dimethyl labeling for quantitative proteomics.

Boersema PJ, Raijmakers R, Lemeer S, Mohammed S, Heck AJ.

Nat Protoc. 2009;4(4):484-94. doi: 10.1038/nprot.2009.21.

PMID:
19300442
43.

Comparative multiplexed mass spectrometric analyses of endogenously expressed yeast nuclear and cytoplasmic exosomes.

Synowsky SA, van Wijk M, Raijmakers R, Heck AJ.

J Mol Biol. 2009 Jan 30;385(4):1300-13. doi: 10.1016/j.jmb.2008.11.011. Epub 2008 Nov 20.

PMID:
19046973
44.

Kinetics of human peptidylarginine deiminase 2 (hPAD2)--reduction of Ca2+ dependence by phospholipids and assessment of proposed inhibition by paclitaxel side chains.

Musse AA, Polverini E, Raijmakers R, Harauz G.

Biochem Cell Biol. 2008 Oct;86(5):437-47. doi: 10.1139/o08-124.

PMID:
18923545
45.

Automated online sequential isotope labeling for protein quantitation applied to proteasome tissue-specific diversity.

Raijmakers R, Berkers CR, de Jong A, Ovaa H, Heck AJ, Mohammed S.

Mol Cell Proteomics. 2008 Sep;7(9):1755-62. doi: 10.1074/mcp.M800093-MCP200. Epub 2008 Jun 4.

46.

Myelin localization of peptidylarginine deiminases 2 and 4: comparison of PAD2 and PAD4 activities.

Wood DD, Ackerley CA, Brand Bv, Zhang L, Raijmakers R, Mastronardi FG, Moscarello MA.

Lab Invest. 2008 Apr;88(4):354-64. doi: 10.1038/labinvest.3700748. Epub 2008 Jan 28.

47.

Synthetic peptides: the future of patient management in systemic rheumatic diseases?

Kessenbrock K, Raijmakers R, Fritzler MJ, Mahler M.

Curr Med Chem. 2007;14(26):2831-8. Review.

PMID:
18045129
48.

ABAP: antibody-based assay for peptidylarginine deiminase activity.

Zendman AJ, Raijmakers R, Nijenhuis S, Vossenaar ER, Tillaart Mv, Chirivi RG, Raats JM, van Venrooij WJ, Drijfhout JW, Pruijn GJ.

Anal Biochem. 2007 Oct 15;369(2):232-40. Epub 2007 Jul 21.

PMID:
17716614
49.

Novel aspects of autoantibodies to the PM/Scl complex: clinical, genetic and diagnostic insights.

Mahler M, Raijmakers R.

Autoimmun Rev. 2007 Aug;6(7):432-7. Epub 2007 Feb 20. Review.

PMID:
17643929
50.

C1D is a major autoantibody target in patients with the polymyositis-scleroderma overlap syndrome.

Schilders G, Egberts WV, Raijmakers R, Pruijn GJ.

Arthritis Rheum. 2007 Jul;56(7):2449-54.

Supplemental Content

Loading ...
Support Center